Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582530 · ClinicalTrials.gov registry record
Men Undergoing Radical Prostatectomy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 513
- Enrollment target
NCT00582530: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582530 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 513 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582530 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 513 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the protein pattern in your blood can predict whether or not your prostate tumor is aggressive. We will use a new and very sensitive technique, called mass spectroscopy, to measure hundreds of pieces of protein in your blood. A computer will make a picture of the protein pattern. We will do this in 500 men before their prostate surgery and see if there is a pattern that predicts what the tumor looks like under the microscope. We will also check the protein pattern in your blood 6 weeks to 12 months after the surgery to see if your pattern changes.
Interventions
- OTHER Whole Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2004-12-28 |
| Est. Completion | 2022-06-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582530
The ClinicalTrials.gov registry entry for NCT00582530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 513 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole Blood Draw is the first listed.
NCT00582530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582530 about?
NCT00582530 is a clinical study titled "Men Undergoing Radical Prostatectomy". The purpose of this study is to see if the protein pattern in your blood can predict whether or not your prostate tumor is aggressive. We will use a new and very sensitive technique, called mass spectroscopy, to measure hundreds of pieces of protein in your blood. A computer will make a picture of t...
What is the current status of trial NCT00582530?
This trial is currently completed. The enrollment target is 513 participants. The study started on 2004-12-28. Estimated completion is 2022-06-21.
What interventions are being tested in trial NCT00582530?
The interventions under investigation include: Whole Blood Draw (OTHER).
Who is sponsoring clinical trial NCT00582530?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.